Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Postmarket User Fees Floated At House Subcommittee Hearing

This article was originally published in The Gray Sheet

Executive Summary

The chairman of the House subcommittee overseeing reauthorization of medical device user fees is signaling that he might push to have a portion of industry-provided funds specifically allocated for FDA postmarket activities
Advertisement

Related Content

FDA User Fee Reauthorization Bill Cleared For House Floor Action
FDA User Fee Reauthorization Bill Cleared For House Floor Action
Survey Suggests Industry Aversion To Facility Registration Fee
Survey Suggests Industry Aversion To Facility Registration Fee
Senate Passes User Fee Reauthorization With FDA/Industry Proposals Intact
MDUFMA Renewal Plan Spreads Fee Burden More Evenly; Senate Panel OKs
FDA’s Third-Party Inspection Program “Here To Stay,” Agency Official Says
Device Center Director Schultz Floats User Fees For Postmarket Efforts
Device Center Director Schultz Floats User Fees For Postmarket Efforts
Advertisement
UsernamePublicRestriction

Register

MT024827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel